Biocon Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Biocon Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Biocon Ltd.
Rating: 5
Author: Geojit BNP Paribas

Keep track of all breaking news and updates on Biocon Ltd. from all sources in a single place.

Load latest

Biocon Ltd.

03 Feb 2021

340.65

2.45%

Company Update

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Investor Meeting

pdf

Biocon Ltd.

02 Feb 2021

340.65

2.45%

Neutral Biocon; target of Rs 385: Motilal Oswal

Moneycontrol

Motilal Oswal recommended Neutral rating on Biocon with a target price of Rs 385 in its research report dated January 22, 2021.

Biocon Ltd. is trading below its 100 day SMA of 346.9

Biocon Ltd.

02 Feb 2021

340.65

2.45%

Company Update

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Investor Meeting

pdf

Biocon Ltd.

02 Feb 2021

340.65

2.45%

BIOCON LTD

Buy: Biocon Ltd.

Target

Geojit BNP Paribas

the integrated drug discovery platform (IDD) with four new projects from Deerfield 550 Discovery and Development (3DC). However, revenue from Generics segment declined 450 2.7% YoY to Rs. 561cr, impacted by advance buying owing to pandemic, supply 350 disruption and delay of approval of certain key products. Margin contracted on higher R&D; expenses EBITDA stood at Rs. 427cr, decline of 11.0% YoY, with margin contracting 490bps YoY to 23.1%, mainly due to higher R&D; expenses and employee cost related to Biosimilars business. Gross R&D; spends increased 18.1% YoY to Rs. 183cr and employee cost as a...

Biocon Ltd. has an average target of 389.25 from 4 brokers.

Biocon Ltd.

01 Feb 2021

340.65

2.45%

Buy Biocon; target of Rs 470: Sharekhan

Moneycontrol

Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 470 in its research report dated January 22, 2021.

Biocon Ltd. has an average target of 389.25 from 4 brokers.

Biocon Ltd.

28 Jan 2021

340.65

2.45%

Women's economic empowerment vital to tackle gender inequality: Biocon head

Business Standard

Economic empowerment of women is extremely important to bridge the gap of gender inequality,US-India Business Council Vice Chair and Biocon Executive Chair Kiran Mazumdar-Shaw said on Thursday. Speaking at a virtual event on 'Expanding the US-India Partnership: Promoting Gender Diversity at Work', she said gender inequality starts with the skewed distribution that women face when it comes to the distribution of assets or inheritance or workplace employment or representation in socio-political institutions. "Economic empowerment is what will bridge the gap of gender inequality. I think economic empowerment of the women is extremely important," Mazumdar-Shaw said. Even in the corporate world, there is a lot of tokenism in everything we do, she said. Of the top 100 BSE companies in India, 91 have only one woman director, which means it is just sort of ticking a box. Moreover, when they want to find a woman for the board, it is the same group of women they are looking at. The canvas ha